advisorsecurities master

BCYCBicycle Therapeutics plc American Depositary Shares

ADRCNasdaq (XNAS)·USD

Identity

Security key
12359
Ticker
BCYC
Type
ADRCAmerican Depository Receipt Common
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2019-05-23
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
BCYC

Detail

Enriched 2026-08-14 20:47

Market cap
$284,171,056.26
Shares outstanding (class)
50,554,927
Shares outstanding (weighted)
69,992,871
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
288
Location
CAMBRIDGE, X0
Description

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United Kingdom.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data